Breast Neoplasms Clinical Trials in Taiyuan, Shanxi
2 recruitingTaiyuan, Shanxi, China
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Breast Neoplasms
Bristol-Myers Squibb500 enrolled293 locationsNCT06926868
Recruiting
A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients
Breast NeoplasmsBreast DiseasesQuality of Life (QOL)+1 more
FangYi3,000 enrolled3 locationsNCT07010939